SCHEMBL14721963

SCHEMBL14721963

O=C(NC1CCCC1)c1ccccc1C=C1CCN(C2CCC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
LMNA P02545 2/20 0.47
HPGD P15428 2/20 0.47
KDM4E B2RXH2 2/20 0.47
HTT P42858 1/20 0.47
GAA P10253 2/20 0.45
SIGMAR1 Q99720 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PKM P14618 1/20 0.44
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HRH3 Q9Y5N1 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720988 0.79 SRD5A2 (0.49) ALDH1A1NPC1RAB9AHPGDKDM4E
SCHEMBL14720818 0.78 ALDH1A1 (0.47) ALDH1A1NPC1RAB9AHPGDKDM4E
SCHEMBL14722886 0.72 HRH3 (0.39) ALDH1A1LMNAKDM4EHRH3POLB
SCHEMBL14720677 0.72 SRD5A2 (0.50) ALDH1A1NPC1RAB9ALMNAKDM4E
SCHEMBL30666379 0.72 ALDH1A1 (0.77) ALDH1A1NPC1RAB9ALMNAHPGD
SCHEMBL13813914 0.70 NPC1 (0.46) ALDH1A1NPC1RAB9ALMNAHPGD
SCHEMBL11870030 0.70 NPC1 (0.60) ALDH1A1NPC1RAB9ALMNAHPGD
SCHEMBL11870024 0.70 NPC1 (0.60) ALDH1A1NPC1RAB9ALMNAHPGD
SCHEMBL14721702 0.69 HRH3 (0.39) ALDH1A1KDM4EGAAMEN1KMT2A
SCHEMBL16565831 0.69 NPSR1 (0.60) ALDH1A1NPC1RAB9ALMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed